🇺🇸 Pneumococcal in United States

2,899 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 471 reports (16.25%)
  2. Fatigue — 321 reports (11.07%)
  3. Asthma — 309 reports (10.66%)
  4. Cough — 305 reports (10.52%)
  5. Pain — 282 reports (9.73%)
  6. Headache — 252 reports (8.69%)
  7. Drug Ineffective — 250 reports (8.62%)
  8. Wheezing — 246 reports (8.49%)
  9. Gastrooesophageal Reflux Disease — 235 reports (8.11%)
  10. Chronic Obstructive Pulmonary Disease — 228 reports (7.86%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Pneumococcal approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pneumococcal in United States?

Hospital Clinic of Barcelona is the originator. The local marketing authorisation holder may differ — check the official source linked above.